溶連菌感染症治療の世界市場レポート 2025年

溶連菌感染症治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.8％で27億7,000万米ドルに成長します。予測期間の成長は、抗生物質耐性の出現、遠隔医療の採用、世界ヘルスへの取り組み、高齢化、発展途上地域におけるヘルスケアへのアクセス、医薬品の研究開発投資に起因します。予測期間の主な動向には、遠隔医療の統合、迅速診断検査の革新、AIと機械学習、抗生物質の開発、バイオテクノロジーの進歩、ウェアラブルヘルス技術、電子薬局、デジタルヘルスなどがあります。

細菌感染症の罹患率の増加は、溶連菌感染症治療市場の拡大を促進すると予想されます。細菌感染症は、有害な細菌が体内に侵入して増殖し、毒素を産生することで発生します。細菌感染の増加要因としては、抗生物質の過剰使用、世界の旅行、都市化、不衛生、ヘルスケア関連感染などが挙げられます。溶連菌感染症治療は、これらの感染症に対処するために、効果的な薬物療法やケアを提供し、症状の緩和、罹病期間の短縮、合併症の予防を支援するとともに、医療従事者が患者の転帰を管理し、感染症の蔓延を抑制する上で重要な役割を果たしています。例えば、2023年6月、英国の政府機関であるOffice for Health Improvement and Disparitiesの報告によると、イングランドでは2022-2023年のシーズン中、37週目から46週目までにA群溶血性レンサ球菌による猩紅熱の届出が4,622件記録され、46週目だけで851件の届出があったことが明らかになりました。これは同時期の5年平均1,294件（258件から2,008件の範囲）を大きく上回っています。その結果、細菌感染症の罹患率の上昇が溶連菌感染症治療市場の成長に寄与しています。

溶連菌感染症治療市場の主要企業は、呼吸器感染症やのどの痛みに対する迅速で正確な多重診断検査をポイントオブケアで提供するため、のどの感染症迅速診断薬などの革新的ソリューションの開発に注力しています。これらの進歩は、患者ケアを改善し、抗生物質の誤用を減らすことを目的としています。咽頭感染症の迅速診断には、咽頭のA群溶連菌の存在を迅速に検出し、溶連菌感染症のタイムリーな診断と治療を可能にする迅速溶連菌検査のような検査が含まれます。例えば、2024年6月、フランスの体外診断薬会社bioMerieux社は、BIOFIRE SPOTFIRE Respiratory/Sore Throat（R/ST）Panel Miniを発表しました。この迅速診断検査は、呼吸器感染症や咽頭痛の原因として一般的な5種類のウイルスと細菌を特定することができ、診療の現場で迅速かつ実用的な結果を提供します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界溶連菌感染症治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の溶連菌感染症治療市場：成長率分析
• 世界の溶連菌感染症治療市場の実績：規模と成長, 2019-2024
• 世界の溶連菌感染症治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界溶連菌感染症治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の溶連菌感染症治療市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗生物質
• 鎮痛剤
• その他の治療タイプ
• 世界の溶連菌感染症治療市場診断別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗体検査
• 身体検査
• 咽頭培養検査
• その他の診断
• 世界の溶連菌感染症治療市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• トピック
• 注射剤
• 世界の溶連菌感染症治療市場：疾患タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 急性連鎖球菌性咽頭炎
• 咽頭炎
• 扁桃炎
• 喉頭炎
• その他の病気の種類
• 世界の溶連菌感染症治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 専門クリニック
• 診断検査室
• その他のエンドユーザー
• 世界の溶連菌感染症治療市場抗生物質の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ペニシリン系抗生物質
• アモキシシリン系抗生物質
• セファロスポリン
• マクロライド
• 世界の溶連菌感染症治療市場鎮痛剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 非ステロイド性抗炎症薬（NSAID）
• アセトアミノフェン
• 局所用喉スプレーまたはロゼンジ
• 世界の溶連菌感染症治療市場、その他の治療タイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• コルチコステロイド
• ハーブ療法
• 塩水うがいとその他の家庭療法

第7章 地域別・国別分析

• 世界の溶連菌感染症治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の溶連菌感染症治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 溶連菌感染症治療市場：競合情勢
• 溶連菌感染症治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sanofi SA
• Bristol-Myers Squibb Company
• AstraZeneca plc
• Abbott Laboratories
• Novartis AG
• F. Hoffmann-La Roche AG
• Takeda Pharmaceutical Company Limited
• GlaxoSmithKline plc（GSK）
• C.H. Boehringer Sohn AG and Co. KG
• Eli Lilly and Company
• Amgen Inc.
• Novo Nordisk A/S
• Reckitt Benckiser Pharmaceuticals Inc.
• Teva Pharmaceutical Industries Ltd.
• Daiichi Sankyo Company Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 溶連菌感染症治療市場2029：新たな機会を提供する国
• 溶連菌感染症治療市場2029：新たな機会を提供するセグメント
• 溶連菌感染症治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Strep throat is caused by Group A Streptococcus bacteria, leading to infection primarily in the throat and tonsils. Symptoms include sore throat, difficulty swallowing, fever, swollen lymph nodes, and occasionally white patches on the tonsils. Treatment typically involves antibiotics such as penicillin or amoxicillin, along with pain relievers, rest, and fluids to manage symptoms, prevent complications, and support recovery.

Treatment for strep throat generally consists of antibiotics, pain relievers, and other supportive measures. Antibiotics are medications that kill or inhibit bacterial growth, serving as the primary treatment for strep throat by targeting the streptococcal bacteria responsible for the infection. Diagnosis methods include antibody tests, physical examinations, and throat cultures. Treatment options vary by type, including acute strep throat, pharyngitis, tonsillitis, and laryngitis, with administration routes such as oral, topical, or injectable. End users include hospitals, specialty clinics, diagnostic laboratories, and others.

The strep throat treatment market research report is one of a series of new reports from the business research company that provides strep throat treatment market statistics, including strep throat treatment industry global market size, regional shares, competitors with an strep throat treatment market share, detailed strep throat treatment market segments, market trends and opportunities, and any further data you may need to thrive in the strep throat treatment industry. This strep throat treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The strep throat treatment market size has grown strongly in recent years. It will grow from $2.08 billion in 2024 to $2.21 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to the rising prevalence of streptococcal infections, increased awareness and diagnosis, antibiotic accessibility, healthcare infrastructure, government health initiatives, a rising pediatric population, and economic growth.

The strep throat treatment market size is expected to see strong growth in the next few years. It will grow to $2.77 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to emerging antibiotic resistance, telemedicine adoption, global health initiatives, an aging population, healthcare access in developing regions, and pharmaceutical R&D investments. Major trends in the forecast period include telemedicine integration, rapid diagnostic test innovation, AI and machine learning, antibiotic development, biotechnology advances, wearable health technology, e-pharmacies, and digital health.

The growing incidence of bacterial infections is expected to drive the expansion of the strep throat treatment market. Bacterial infections occur when harmful bacteria invade the body, multiply, and produce toxins. Contributing factors to the rise in bacterial infections include antibiotic overuse, global travel, urbanization, poor hygiene, and healthcare-associated infections. Strep throat treatment plays a crucial role in addressing these infections by offering effective medication and care, which helps alleviate symptoms, shorten the duration of illness, and prevent complications, while also aiding healthcare providers in managing patient outcomes and curbing the spread of infections. For instance, in June 2023, a report from the Office for Health Improvement and Disparities, a UK-based governmental body, revealed that 4,622 notifications of scarlet fever caused by Group A Streptococcus bacteria were recorded from week 37 to week 46 during the 2022-2023 season in England, with 851 notifications in week 46 alone. This is significantly higher than the five-year average of 1,294 notifications (ranging from 258 to 2,008) for the same period. As a result, the rising incidence of bacterial infections is contributing to the growth of the strep throat treatment market.

Major companies in the strep throat treatment market are focusing on developing innovative solutions, such as rapid throat infection diagnostics, to offer fast, accurate, and multiplex diagnostic testing for respiratory and sore throat infections at the point of care. These advancements aim to improve patient care and reduce antibiotic misuse. Rapid throat infection diagnostics include tests like the rapid strep test, which swiftly detects the presence of group A streptococcus bacteria in the throat, allowing for timely diagnosis and treatment of strep throat. For example, in June 2024, bioMerieux, a France-based in vitro diagnostics company, introduced its BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panel Mini. This rapid diagnostic test can identify five common viral and bacterial causes of respiratory and sore throat infections, providing quick and actionable results at the point of care.

In August 2022, GSK plc, a UK-based pharmaceutical manufacturing company, acquired Affinivax, Inc. for approximately $3.3 billion. This acquisition is designed to enhance GSK's portfolio of novel vaccines, with a particular focus on advancing next-generation pneumococcal vaccines through the innovative MAPSTM technology platform. Affinivax, Inc., a U.S.-based biopharmaceutical company, specializes in the development of vaccines for infectious and immune-mediated diseases.

Major companies operating in the strep throat treatment market are Pfizer Inc., Johnson And Johnson, Merck And Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, F. Hoffmann-La Roche AG, Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc (GSK), C.H. Boehringer Sohn AG And Co. KG, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Reckitt Benckiser Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Astellas Pharma Inc., Biogen Inc., Vertex Pharmaceuticals, Eisai Co. Ltd., Mylan N.V

North America was the largest region in the strep throat treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the strep throat treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the strep throat treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The strep throat treatment market consists of revenues earned by entities through services such as, antibiotic prescriptions, pain relief management, supportive care, and follow-up consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. The strep throat treatment market also includes sales of throat lozenges and supportive care items such as throat sprays and herbal remedies. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Strep Throat Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on strep throat treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for strep throat treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The strep throat treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Antibiotics; Pain Relievers; Other Treatment Type
• 2) By Diagnosis: Antibody Test; Physical Examination; Throat Culture; Other Diagnosis
• 3) By Route Of Administration: Oral; Topical; Injectable
• 4) By Disease Type: Acute Strep Throat; Pharyngitis; Tonsillitis; Laryngitis; Other Disease Type
• 5) By End-Users: Hospitals; Specialty Clinics; Diagnostic Laboratories; Other End-Users
• Subsegments:
• 1) By Antibiotics: Penicillin-Based Antibiotics; Amoxicillin-Based Antibiotics; Cephalosporins; Macrolides
• 2) By Pain Relievers: Non-Steroidal Anti-Inflammatory Drugs (Nsaids); Acetaminophen; Topical Throat Sprays Or Lozenges
• 3) By Other Treatment Types: Corticosteroids; Herbal Remedies; Saltwater Gargles And Other Home Remedies
• Companies Mentioned: Pfizer Inc.; Johnson And Johnson; Merck And Co. Inc.; AbbVie Inc.; Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Strep Throat Treatment Market Characteristics

3. Strep Throat Treatment Market Trends And Strategies

4. Strep Throat Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Strep Throat Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Strep Throat Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Strep Throat Treatment Market Growth Rate Analysis
• 5.4. Global Strep Throat Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Strep Throat Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Strep Throat Treatment Total Addressable Market (TAM)

6. Strep Throat Treatment Market Segmentation

• 6.1. Global Strep Throat Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibiotics
• Pain Relievers
• Other Treatment Type
• 6.2. Global Strep Throat Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibody Test
• Physical Examination
• Throat Culture
• Other Diagnosis
• 6.3. Global Strep Throat Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Topical
• Injectable
• 6.4. Global Strep Throat Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Strep Throat
• Pharyngitis
• Tonsillitis
• Laryngitis
• Other Disease Type
• 6.5. Global Strep Throat Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Diagnostic Laboratories
• Other End-Users
• 6.6. Global Strep Throat Treatment Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Penicillin-Based Antibiotics
• Amoxicillin-Based Antibiotics
• Cephalosporins
• Macrolides
• 6.7. Global Strep Throat Treatment Market, Sub-Segmentation Of Pain Relievers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
• Acetaminophen
• Topical Throat Sprays Or Lozenges
• 6.8. Global Strep Throat Treatment Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Corticosteroids
• Herbal Remedies
• Saltwater Gargles And Other Home Remedies

7. Strep Throat Treatment Market Regional And Country Analysis

• 7.1. Global Strep Throat Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Strep Throat Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Strep Throat Treatment Market

• 8.1. Asia-Pacific Strep Throat Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Strep Throat Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Strep Throat Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Strep Throat Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Strep Throat Treatment Market

• 9.1. China Strep Throat Treatment Market Overview
• 9.2. China Strep Throat Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Strep Throat Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Strep Throat Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Strep Throat Treatment Market

• 10.1. India Strep Throat Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Strep Throat Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Strep Throat Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Strep Throat Treatment Market

• 11.1. Japan Strep Throat Treatment Market Overview
• 11.2. Japan Strep Throat Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Strep Throat Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Strep Throat Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Strep Throat Treatment Market

• 12.1. Australia Strep Throat Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Strep Throat Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Strep Throat Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Strep Throat Treatment Market

• 13.1. Indonesia Strep Throat Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Strep Throat Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Strep Throat Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Strep Throat Treatment Market

• 14.1. South Korea Strep Throat Treatment Market Overview
• 14.2. South Korea Strep Throat Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Strep Throat Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Strep Throat Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Strep Throat Treatment Market

• 15.1. Western Europe Strep Throat Treatment Market Overview
• 15.2. Western Europe Strep Throat Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Strep Throat Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Strep Throat Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Strep Throat Treatment Market

• 16.1. UK Strep Throat Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Strep Throat Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Strep Throat Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Strep Throat Treatment Market

• 17.1. Germany Strep Throat Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Strep Throat Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Strep Throat Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Strep Throat Treatment Market

• 18.1. France Strep Throat Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Strep Throat Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Strep Throat Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Strep Throat Treatment Market

• 19.1. Italy Strep Throat Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Strep Throat Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Strep Throat Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Strep Throat Treatment Market

• 20.1. Spain Strep Throat Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Strep Throat Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Strep Throat Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Strep Throat Treatment Market

• 21.1. Eastern Europe Strep Throat Treatment Market Overview
• 21.2. Eastern Europe Strep Throat Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Strep Throat Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Strep Throat Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Strep Throat Treatment Market

• 22.1. Russia Strep Throat Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Strep Throat Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Strep Throat Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Strep Throat Treatment Market

• 23.1. North America Strep Throat Treatment Market Overview
• 23.2. North America Strep Throat Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Strep Throat Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Strep Throat Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Strep Throat Treatment Market

• 24.1. USA Strep Throat Treatment Market Overview
• 24.2. USA Strep Throat Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Strep Throat Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Strep Throat Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Strep Throat Treatment Market

• 25.1. Canada Strep Throat Treatment Market Overview
• 25.2. Canada Strep Throat Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Strep Throat Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Strep Throat Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Strep Throat Treatment Market

• 26.1. South America Strep Throat Treatment Market Overview
• 26.2. South America Strep Throat Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Strep Throat Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Strep Throat Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Strep Throat Treatment Market

• 27.1. Brazil Strep Throat Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Strep Throat Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Strep Throat Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Strep Throat Treatment Market

• 28.1. Middle East Strep Throat Treatment Market Overview
• 28.2. Middle East Strep Throat Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Strep Throat Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Strep Throat Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Strep Throat Treatment Market

• 29.1. Africa Strep Throat Treatment Market Overview
• 29.2. Africa Strep Throat Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Strep Throat Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Strep Throat Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Strep Throat Treatment Market Competitive Landscape And Company Profiles

• 30.1. Strep Throat Treatment Market Competitive Landscape
• 30.2. Strep Throat Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Strep Throat Treatment Market Other Major And Innovative Companies

• 31.1. Sanofi SA
• 31.2. Bristol-Myers Squibb Company
• 31.3. AstraZeneca plc
• 31.4. Abbott Laboratories
• 31.5. Novartis AG
• 31.6. F. Hoffmann-La Roche AG
• 31.7. Takeda Pharmaceutical Company Limited
• 31.8. GlaxoSmithKline plc (GSK)
• 31.9. C.H. Boehringer Sohn AG and Co. KG
• 31.10. Eli Lilly and Company
• 31.11. Amgen Inc.
• 31.12. Novo Nordisk A/S
• 31.13. Reckitt Benckiser Pharmaceuticals Inc.
• 31.14. Teva Pharmaceutical Industries Ltd.
• 31.15. Daiichi Sankyo Company Limited

32. Global Strep Throat Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Strep Throat Treatment Market

34. Recent Developments In The Strep Throat Treatment Market

35. Strep Throat Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Strep Throat Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Strep Throat Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Strep Throat Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer